Evidence map›Paper›PMID 29581534›Full record

ArticleScientific reports2018

MicroRNA-1 suppresses proliferation, migration and invasion by targeting Notch2 in esophageal squamous cell carcinoma.

Wenzhi Liu, Mengkao Li, Xiangming Chen, Shan Zhu, Hailong Shi, Dawei Zhang, Cheng Cheng, Baosheng Li

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. [microRNA-1 gene delivery mediated by exosomes suppresses CAL-27 cell proliferation].Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Emerging Role of Non-Coding RNAs in Esophageal Squamous Cell Carcinoma.International journal of molecular sciences · 2019
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Wenzhi LiuDepartment of Clinical Oncology, Taian City Central Hospital, Taian, Shandong Province, P. R. China.
Mengkao LiDepartment of Neurosurgery, Taian City Central Hospital, Taian, Shandong Province, P. R. China.
Xiangming ChenDepartment of Clinical Oncology, Taian City Central Hospital, Taian, Shandong Province, P. R. China.
Shan ZhuDepartment of Oncology, Shandong Provincial Western Hospital, Jinan, Shandong Province, P. R. China.
Hailong ShiDepartment of Clinical Oncology, Taian City Central Hospital, Taian, Shandong Province, P. R. China.
Dawei ZhangTrauma orthopedics ward, Zibo Central Hospital, Zibo, Shandong Province, P. R. China.
Cheng ChengCardiovascular department ward, Zibo Central Hospital, Zibo, Shandong Province, P. R. China.
Baosheng LiDepartment of Radiation Oncology, Shandong Cancer Hospital Affiliated to Shandong University, Jinan, Shandong Province, P. R. China. baoshli1963@163.com.
Taian City Central Hospital · CNCentral Hospital of Zibo · CNShandong First Medical University · CNShandong Provincial Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MicroRNAs play an important role in the migration and invasion of tumors, and lower expression of microRNA-1 (miR-1) has been proven in a variety of malignant tumors, including esophageal squamous cell carcinoma (ESCC). In this study, we found that miR-1 expression levels in tumor tissues and preoperative serum from esophageal carcinoma patients were lower than those in non-tumorous tissues and healthy volunteers. miR-1 expression in tissues and plasma was closely related to invasion, lymph node metastasis and TNM staging. Additionally, miR-1 expression levels in tissues and plasma were positively correlated. miR-1 inhibited cell proliferation, migration and invasion. Overexpression of miR-1 in ESCC cells reduced Notch2 protein but not mRNA levels, whereas suppression of miR-1 led to an increase in Notch2 protein but not mRNA levels. A dual-luciferase experiment validated that Notch2 was a direct target of miR-1. Introducing Notch2 mRNA into cells over-expressing miR-1 partially abrogated the effects of miR-1 on migration and invasion. Further studies verified that miR-1 regulates EMT signalling pathways directly through Notch2. Therefore, these results confirm that, as a tumor suppressor gene, miR-1 may be a potential tumor marker for the early diagnosis of ESCC and a new drug target.

Indexed as

Biomarkers, TumorCell Line, TumorCell MovementCell ProliferationEpithelial-Mesenchymal TransitionEsophageal Squamous Cell CarcinomaFemaleGene Expression Regulation, NeoplasticHumansLymphatic MetastasisMaleMicroRNAsNeoplasm InvasivenessReceptor, Notch2RNA, MessengerSignal TransductionBiomarkers, TumorMicroRNAsMIRN1 microRNA, humanNOTCH2 protein, humanReceptor, Notch2RNA, Messenger

Identifiers

PMID29581534
PMCPMC5979967
OpenAlexW2805218040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.